Sanofi has released additional positive results from the global GetGoal Phase III development program with Lyxumia (lixisenatide) for the treatment of type 2 diabetes. Lyxumia (lixisenatide), a once-daily GLP-1 receptor agonist, was invented by Zealand Pharma and global rights are with Sanofi...
The Obama administration has taken a rare step and urged the California courts to allow school employees to administer insulin shots to the state's 14,000 diabetic schoolchildren if no nurses are available, according to the San Francisco Chronicle...
U.S. District Court for the Southern District of California granted Amylin Pharmaceuticals a temporary restraining order (TRO) related to its litigation with respect to the Amylin / Lilly diabetes collaboration agreement...
The day my diagnosis essay posted was a great one for boosting the feeling of community with my diabetes care. I was touched to read the comment thread…
Last week, after returning from my appointment at the diabetes clinic I picked Tom and Guy up from school and took them out to lunch at a nearby cafe. …